Stocks
Halozyme (HALO) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 47.8% | 47.8% | 54.5% | 64.7% | 64.8% | 63.7% | ||
| Changes by years, y/y, % | -11pp | 0pp | +7pp | +10pp | +0pp | +2.5% | |||
Halozyme. EBITDA margin, %
Halozyme. EBITDA margin, changes, pp
Halozyme (HALO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 61.2% | 68.4% | 67.3% | 62.2% | 57.9% | 63.7% | |
| Changes by years, y/y, % | +2pp | +9pp | +2pp | -6pp | -3pp | |||
| Changes by quarters, q/q, % | -7pp | +7pp | -1pp | -5pp | -4pp | |||
